NextGen Omics US 2024

21 - 22 March 2024 | Boston, MA

Leveraging multi-omic data to unlock transformative insights into cellular biology, disease and drug discovery

Presentation Speaker
Overview Next Generation Sequencing & Clinical Diagnostics Single Cell & Spatial Analysis
+co-located event:
Synthetic Biology US 2024

Explore NextGen Omics US 2024: Delivering Therapeutic Innovation Through Multi-Omic Analysis

With technological advancements in NGS, single cell analysis and more, we have more data than ever to understand disease drivers – facilitating a transformative shift towards precision medicine. NextGen Omics US connects experts from across genomic, transcriptomics, proteomics and metabolomics to fast-track the adoption of multi-omic techniques within drug discovery and clinical research. Encompassing our 9th Annual Next Generation Sequencing US Congress and 9th Annual Single Cell & Spatial Analysis US Congress, you'll be able to discuss the industry’s most pressing challenges – from data analysis and reproducibility through to sample management – and build partnerships with the right people for your research goals.

9th Annual Next Generation Sequencing & Clinical Diagnostics US Congress

Expand the applications of next-generation sequencing in your clinical & diagnostic workflows through the Next Generation Sequencing & Clinical Diagnostics US Congress, highlighting the most need-to-know innovations in diagnostics, clinical genomics & bioinformatic technologies. Industry leading speakers will showcase effective strategies for integrating NGS techniques within drug development, with further discussion on standardizing bioinformatics, optimizing NGS-based assays and utilizing multi-omic data.

  • Over 450 end users representing internationally renowned research & academic institutions, healthcare organisations and leading biopharma institutions
  • Over 20 presentations focussed on the critical issues in NGS implementation and data integration

Agenda at a Glance


Day One | Track 1: Clinical Multi-Omics 

Day Two | Track 1: Diagnostics Development & Multi-Omics Bioinformatics

9th Annual Single Cell Analysis US Congress

Recent advances in single cell analytical tools have enabled increasingly deep cellular analyses at the genomic, transcriptomic and proteomic level. Join the Single Cell Analysis Congress to learn how to integrate the most exciting new techniques within drug development, from identifying novel therapeutic targets through to understanding patient responses to specific therapies. In-depth case studies also showcase emerging spatial approaches, with discussion on how to optimize their use within R&D.

  • Over 450 end users representing internationally renowned research & academic institutions, healthcare organisations and leading biopharma institutions
  • Over 40 presentations focussed on the most innovative spatial and single cell technologies, and their applications within diagnostics, clinical research and drug discovery

Agenda at a Glance


Day One | Track 2: Novel Spatial Technologies

Day One | Track 3: Emerging Single Cell Analysis Technologies & Tools

Day Two | Track 2: Applications of Spatial Technologies & Bioinformatics

Day Two | Track 3: Applications of Single Cell Analysis in Pharma R&D and Clinic

3rd Annual Synthetic Biology US Congress

Attendees of NextGen Omics US 2024 also have access to Synthetic Biology US 2024

Explore Synthetic Biology US 2024: Rewriting The Rules Of Biological Systems

Gain insights into enhanced gene engineered and synthetic biology to develop more targeted, controlled and safe therapeutic outcomes. From its applications in cell & gene therapy and mRNA therapies through to the use of AI/ML to optimize engineering, this in-depth 2 day meeting delves into the most innovative technologies in synthetic biology for drug discovery.

  • Discover innovative synthetic biology tools for the discovery of new drug targets and production optimization. This highly anticipated event brings together key opinion leaders to discuss emerging next gen technologies to develop cell-free systems and engineer complex traits & genetic circuits.   
  • Learn about CRISPR-based therapeutics in drug discovery, speeding up the development of new therapeutics with synthetic biology, biosynthesis of therapeutic compounds and applications in immuno-oncology. 
  • Maximise your event experience with exclusive interactive programme features such as workshops, panel discussions and roundtables, tapping into the priorities & challenges of the wider genome editing market.

Agenda at a Glance


  • Day One | Track 1: Synthetic Biology Tools For Drug Discovery, AI/ Machine Learning & Computational Approaches
  • Day Two | Track 1: Synthetic Biology-based Therapeutics

What to Expect

400

leading pharma, biotech, & academic delegates

41
hours of presentations, discussions & interactive content
11
hours of networking breaks, including speed networking & refreshments
62
hours of pre-arranged 1-2-1 meetings, facilitating business growth
Interactive Presentations
Exhibition Hall
Networking Drinks
Poster Display
Event App Swapcard

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences

  • Engaging Thought Leadership

    Over 80 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
  • Global Technological Showcase

    An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field.
  • Networking Emphasis

    Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections
  • Innovative Poster Displays

    Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions

Companies Represented Include

Meet Our Expert Speakers

NextGen Omics US 2024 again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.

Below are some of our featured speakers:

Anna Lyubetskaya
Senior Principal Scientist,
Bristol-Myers Squibb Co.
Bin Li
Director, Computational Biology,
Takeda
Colles Price
Principal Scientist,
Takeda
Jasmine Plummer
Director,
St Jude Children's Research Hospital
Jindan Yu
Acting Professor and Vice Chair for Urological Research,
Matcon
Marina Bleck
Principal Scientist,
Boehringer Ingelheim RCV GmbH & Co KG

All Speakers

Ali Rahnavard
Assistant Professor,
The George Washington University
Amrut Sarangi
Computational Scientist,
Sanofi
Asaf Rotem
Senior Director,
AstraZeneca
Ashley Fletcher
Laboratory Manager / Bioinformatician,
Duke Global Health Institute
Cory White
Principal Scientist,
Merck
Deidre Dalmas
Scientific Director,
GSK
Jason Kim
Professor and Director,
10x Genomics
Jeremy Huang
Senior Scientist - Single Cell & Systems Biology,
Sanofi
Jonathan Zhao
Associate Professor,
Emory University
Josee Champagne
Associate Director, Clinical Development,
Northern Therapeutics
Josh Fienman
Scientist, Genomics,
Pfizer Ltd
Jun Wang
Associate Professor,
Stony Brook University New York
Kan Xiong
Research Scientist,
Broad Institute
Katy Borner
Victor H. Yngve Professor of Intelligent Systems Engineering,
Indiana University Bloomington
Kyoung Jae Won Won
Professor,
Cedars-Sinai Medical Center
Liguo Wang
Associate Professor in Biomedical Informatics,
Mayo Clinic
Lindsey Erion Barner
Senior Scientist,
Broad Institute of MIT and Harvard
Mandovi Chatterjee
Director, Single Cell Core,
Harvard Medical School
Monika Mehta
Senior Genomics Scientist,
Frederick National Laboratory for Cancer Research
Nikolai Slavov
Professor,
Northeastern University
Ron Weiss
Professor,
MIT
Serena Dollive
Senior Scientist II,
Oxford Biomedica
Shameer Khader
Executive Director,
Sanofi
Shuqiang Li
Senior Scientist,
Broad Institute
Thomas Defay
Deputy Head of Diagnostics Strategy and Development,
Alexion, AstraZeneca Rare Disease
Towia Libermann
Associate Professor of Medicine,
Beth Israel Deaconess Medical Center
Tujin Shi
Senior Scientist,
Pacific Northwest National Laboratory
Winston Hide
Associate Professor,
Beth Israel Deaconess Medical Center / Harvard Medical School
Xingyi Shi
Expert II, Data Science,
Novartis US
Yasser Riazalhosseini
Associate Professor,
McGill University
Yixing Han
Staff Scientist,
National Institutes of Health
Yong Zeng
Professor,
University of Florida

Interested in Sponsoring?

Oxford Global’s range of sponsorship opportunities are highly effective in enabling market immersion and visibility, with direct access to clients and potential customers.

Learn more

Latest Resources

Curio Bioscience Pen Partnership with DNAnexus, Simplifying Data Analysis in Spatial Transcriptomics

The partnership will allow Curio to give access to DNAnexus's bioinformatics platform to some of their customers.

The Future of Healthcare: Exploring the Latest Innovations in Spatial Imaging Techniques for Pharmaceutical Applications

Omics by Oxford Global explore the importance of medical spatial imaging, its applications in surgical planning and pharmaceutical research and the impact of Omics on spatial imaging techniques

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.

Plan Your Visit

Westin Boston Seaport District Hotel
425 Summer Street, Boston, MA 02210 United States

By Air

Boston Logan International Airport is the nearest airport to the venue – 2 miles from the property. For more information, please call +1 800-2356426.

By Public Transport

S The nearest Bus station is South Station. The nearest Subway Station is World Trade Center and South Station. The nearest Train Station is Back Bay Station and South Station. For more information, please visit https://www.mbta.com/stops/place-aport.

Parking

The parking options at The Westin Boston Seaport District are: $54 per car valet option or $44 per self-parking option.

Information regarding accommodation for this event will be added soon

We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.

As we continue to move forward with hosting our events in-person in 2024, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.

Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.

Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.

If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of NextGen Omics US 2024 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.

Register Your Interest

Submit your details and a member of our team will be in touch